Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: A nationwide study of hospitalised patients in the United States

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 1, 2014, Pages 105-112

  Singal, A K ^a,b   Salameh, H ^c   Kamath, P S ^b  

^a University of Alabama at Birmingham   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CAUCASIAN; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HUMAN; INFECTION RATE; KIDNEY FAILURE; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN INFECTION; SOFT TISSUE INFECTION; TREND STUDY; UNITED STATES; URINARY TRACT INFECTION;

ADULT; BACTERIAL INFECTIONS; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY; UNITED STATES;

EID: 84902186429     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12797     Document Type: Article

References (30)

1. Gomez F, Ruiz P, Schreiber AD,. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 1994; 331: 1122-8.
2. Bonnel AR, Bunchorntavakul C, Reddy KR,. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 9: 727-38.
3. Borzio M, Salerno F, Piantoni L, et al,. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33: 41-8.
4. Caly WR, Strauss E,. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993; 18: 353-8.
5. Fernandez J, Navasa M, Gomez J, et al,. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.
6. Reuken PA, Pletz MW, Baier M, Pfister W, Stallmach A, Bruns T,. Emergence of spontaneous bacterial peritonitis due to enterococci-risk factors and outcome in a 12-year retrospective study. Aliment Pharmacol Ther 2012; 35: 1199-208.
7. Fernández J, Acevedo J, Castro M, et al,. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012; 55: 1551-61.
8. Wong F, Bernardi M, Balk R, et al,. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005; 54: 718-25.
9. Arvaniti V, D'Amico G, Fede G, et al,. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010; 139: 1246-56, 1256.e1-5.
10. Tandon P, Garcia-Tsao G,. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008; 28: 26-42.
11. Merli M, Lucidi C, Giannelli V, et al,. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol 2010; 8: 979-85.
12. Cadranel JF, Denis J, Pauwels A, et al,. Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patients. J Hepatol 1999; 31: 464-8.
13. Mohan P, Ramu B, Bhaskar E, Venkataraman J,. Prevalence and risk factors for bacterial skin infection and mortality in cirrhosis. Ann Hepatol 2011; 10: 15-20.
14. Lin MN, Tsai CC, Hung TH,. The risk of cellulitis in cirrhotic patients: a nationwide population-based study in taiwan. Gut Liver 2012; 6: 482-5.
15. Rabinovitz M, Prieto M, Gavaler JS, Van Thiel DH,. Bacteriuria in patients with cirrhosis. J Hepatol 1992; 16: 73-6.
16. Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, et al,. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding-an updated Cochrane review. Aliment Pharmacol Ther 2011; 34: 509-18.
17. Bajaj JS, Ananthakrishnan AN, Hafeezullah M, et al,. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: a national and tertiary center perspective. Am J Gastroenterol 2010; 105: 106-13.
18. Foreman MG, Mannino DM, Moss M,. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest 2003; 124: 1016-20.
19. Yoshida H, Hamada T, Inuzuka S, Ueno T, Sata M, Tanikawa K,. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. Am J Gastroenterol 1993; 88: 2067-71.
20. Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH,. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 2013; 95: 755-60.
21. Viasus D, Garcia-Vidal C, Castellote J, et al,. Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine (Baltimore) 2011; 90: 110-8.
22. Thuluvath PJ, Morss S, Thompson R,. Spontaneous bacterial peritonitis-in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol 2001; 96: 1232-6.
23. Pereira G, Guevara M, Fagundes C, et al,. Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study. J Hepatol 2012; 56: 1040-6.
24. Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R,. Severe sepsis in cirrhosis. Hepatology 2009; 50: 2022-33.
25. Kim JH, Lee JS, Lee SH, et al,. Renal dysfunction induced by bacterial infection other than spontaneous bacterial peritonitis in patients with cirrhosis: incidence and risk factor. Gut Liver 2009; 3: 292-7.
26. Bajaj JS, O'Leary JG, Reddy KR, et al,. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 2012; 56: 2328-35.
27. Fasolato S, Angeli P, Dallagnese L, et al,. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 2007; 45: 223-9.
28. Terra C, Guevara M, Torre A, et al,. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005; 129: 1944-53.
29. Bajaj JS, Ratliff SM, Heuman DM, Lapane KL,. Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis. Aliment Pharmacol Ther 2013; 38: 407-14.
30. Howden CW,. Commentary: the link between community-acquired pneumonia and PPI use. Aliment Pharmacol Ther 2012; 36: 1101.